Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹4,656 Cr
up ₹68.1 Cr vs Aug 2022
- Stocks held
- 28
- unchanged
- Top 10 weight
- 67.5%
- of the portfolio in its ten largest
- Cash & debt
- 0.4%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 13
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In September 2022 it disclosed 28 stocks worth ₹4,656 Cr, up ₹68.1 Cr from Aug 2022. Its largest positions were Sun Pharmaceutical Industries Limited (14.9%), Cipla Limited (8.9%), Dr. Reddy's Laboratories Limited (8.2%); the ten largest together made up 67.5% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 80.0% of its equity. Cash and debt stood at 0.4%. Compared with Aug 2022 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
94%
Top-10 weight is higher than 94% of peers
Breadth
11%
Holds more stocks than 11% of peers
Cash
5%
Holds more cash than 5% of peers
Holdings in September 2022
Download CSVEvery line the fund disclosed, with the change against Aug 2022. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 14.88%
- Δ weight
- up 0.66 pts
- Value
- ₹693 Cr
- Δ value
- up ₹40.6 Cr
- Status
- Added
- Weight
- 8.86%
- Δ weight
- down 0.19 pts
- Value
- ₹413 Cr
- Δ value
- down ₹2.8 Cr
- Status
- Trimmed
- Weight
- 8.24%
- Δ weight
- up 0.38 pts
- Value
- ₹384 Cr
- Δ value
- up ₹22.9 Cr
- Status
- Added
- Weight
- 6.57%
- Δ weight
- up 0.01 pts
- Value
- ₹306 Cr
- Δ value
- up ₹4.8 Cr
- Status
- Added
- Weight
- 5.97%
- Δ weight
- up 0.04 pts
- Value
- ₹278 Cr
- Δ value
- up ₹5.9 Cr
- Status
- Added
- Weight
- 5.32%
- Δ weight
- up 0.03 pts
- Value
- ₹248 Cr
- Δ value
- up ₹5.2 Cr
- Status
- Added
- Weight
- 5.26%
- Δ weight
- down 0.38 pts
- Value
- ₹245 Cr
- Δ value
- down ₹14 Cr
- Status
- Trimmed
- Weight
- 4.91%
- Δ weight
- down 1.51 pts
- Value
- ₹229 Cr
- Δ value
- down ₹66 Cr
- Status
- Trimmed
- Weight
- 3.84%
- Δ weight
- down 0.32 pts
- Value
- ₹179 Cr
- Δ value
- down ₹12.2 Cr
- Status
- Trimmed
- Weight
- 3.63%
- Δ weight
- up 0.80 pts
- Value
- ₹169 Cr
- Δ value
- up ₹39.1 Cr
- Status
- Added
- Weight
- 3.62%
- Δ weight
- up 0.33 pts
- Value
- ₹168 Cr
- Δ value
- up ₹17.4 Cr
- Status
- Added
- Weight
- 3.18%
- Δ weight
- down 0.67 pts
- Value
- ₹148 Cr
- Δ value
- down ₹28.6 Cr
- Status
- Trimmed
- Weight
- 2.76%
- Δ weight
- down 0.24 pts
- Value
- ₹129 Cr
- Δ value
- down ₹9.1 Cr
- Status
- Trimmed
- Weight
- 2.70%
- Δ weight
- down 0.40 pts
- Value
- ₹126 Cr
- Δ value
- down ₹16.5 Cr
- Status
- Trimmed
- Weight
- 2.69%
- Δ weight
- up 0.24 pts
- Value
- ₹125 Cr
- Δ value
- up ₹12.7 Cr
- Status
- Added
- Weight
- 2.66%
- Δ weight
- up 0.28 pts
- Value
- ₹124 Cr
- Δ value
- up ₹14.4 Cr
- Status
- Added
- Weight
- 2.63%
- Δ weight
- up 1.11 pts
- Value
- ₹122 Cr
- Δ value
- up ₹52.5 Cr
- Status
- Added
- Weight
- 2.62%
- Δ weight
- up 0.10 pts
- Value
- ₹122 Cr
- Δ value
- up ₹6.5 Cr
- Status
- Added
- Weight
- 1.99%
- Δ weight
- up 0.16 pts
- Value
- ₹92.6 Cr
- Δ value
- up ₹8.5 Cr
- Status
- Added
- Weight
- 1.97%
- Δ weight
- down 0.18 pts
- Value
- ₹91.7 Cr
- Δ value
- down ₹7 Cr
- Status
- Trimmed
- Weight
- 1.29%
- Δ weight
- down 0.14 pts
- Value
- ₹60.2 Cr
- Δ value
- down ₹5.6 Cr
- Status
- Trimmed
- Weight
- 1.18%
- Δ weight
- up 0.19 pts
- Value
- ₹55 Cr
- Δ value
- up ₹9.6 Cr
- Status
- Added
- Weight
- 0.69%
- Δ weight
- up 0.01 pts
- Value
- ₹32 Cr
- Δ value
- up ₹1 Cr
- Status
- Added
- Weight
- 0.61%
- Δ weight
- down 0.19 pts
- Value
- ₹28.4 Cr
- Δ value
- down ₹8.3 Cr
- Status
- Trimmed
- Weight
- 0.55%
- Δ weight
- up 0.07 pts
- Value
- ₹25.6 Cr
- Δ value
- up ₹3.8 Cr
- Status
- Added
- Weight
- 0.40%
- Δ weight
- down 0.17 pts
- Value
- ₹18.8 Cr
- Δ value
- down ₹7.3 Cr
- Status
- Trimmed
- Weight
- 0.40%
- Δ weight
- down 0.02 pts
- Value
- ₹18.5 Cr
- Δ value
- down ₹80 L
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 0.36%
- Δ weight
- up 0.05 pts
- Value
- ₹16.6 Cr
- Δ value
- up ₹2.4 Cr
- Status
- Added
- Weight
- 0.25%
- Δ weight
- down 0.03 pts
- Value
- ₹11.5 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
What changed, Aug 2022 to Sep 2022
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Vijaya Diagnostic Centre Limitedup ₹52.5 Cr (+1.11% pts)
- Sun Pharmaceutical Industries Limitedup ₹40.6 Cr (+0.66% pts)
- Apollo Hospitals Enterprise Limitedup ₹39.1 Cr (+0.80% pts)
- Dr. Reddy's Laboratories Limitedup ₹22.9 Cr (+0.38% pts)
- JB Chemicals & Pharmaceuticals Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Aug 2022, the weight rose most in Healthcare Services (+0.9 pts), and fell most in Pharmaceuticals & Biotechnology (−0.6 pts) and Healthcare Equipment & Supplies (−0.2 pts).
- Healthcare Services17.4% → 18.3%+0.9 pts
- Pharmaceuticals & Biotechnology80.6% → 80.0%−0.6 pts
- Healthcare Equipment & Supplies0.6% → 0.4%−0.2 pts
- Pharmaceuticals1.4% → 1.3%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Sep 2019 | Sep 2021 | Mar 2022 | Jun 2022 | Aug 2022 | Sep 2022 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 78.9% | 76.1% | 76.8% | 80.3% | 80.6% | 80.0% |
| Healthcare Services | 20.3% | 21.8% | 20.8% | 17.4% | 17.4% | 18.3% |
| Pharmaceuticals | 0.7% | 2.1% | 1.8% | 1.7% | 1.4% | 1.3% |
| Healthcare Equipment & Supplies | — | — | 0.6% | 0.6% | 0.6% | 0.4% |
Allocation in Sep 2022change vs Aug 2022
- Pharmaceuticals & Biotechnology (19)80.0%▼ 0.6 pts
- Healthcare Services (7)18.3%▲ 0.9 pts
- Pharmaceuticals (1)1.3%▼ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Sep 2022
0.4%
unchanged vs Aug 2022
- Cash alone
- 0.3%
- cash and net receivables
- A year earlier
- 4.1%
- Sep 2021 · now ▼ 3.8 pts
- Last 12 months
- 0.3% – 4.6%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.